Omniscient Neurotechnology Launches Quicktome^™ Brain Mapping Platform for Neurosurgery after Regulatory Clearance in United States, Canada and Australia

Omniscient Neurotechnology, Inc. announced that it has received US FDA 510(k) clearance for Quicktome^™, a digital brain mapping platform that allows neurosurgeons to visualize and understand a patient’s brain networks prior to performing life-changing brain surgery.